Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines
Pharmaceuticals · 16.09.2025 · 18 (9) · 1385
DOI: 10.3390/ph18091385 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 16.09.2025. Verfasst von Luis Vitetta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Sydney School of Pharmacy, Faculty of Medicine and Health, Camperdown Campus, The University of Sydney, Sydney, NSW 2060,…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The application of nanoparticles as nanomedicines, particularly for the targeted and efficacious delivery of drugs is an expanding platform in the field of cannabinoid and pharmaceutical drug delivery. By refocusing the route of drug administration beyond the oral gut pathway, this technology provides significant advancements that are especially relevant for cancer treatments. Orally administered drugs face significant challenges as they traverse the gastrointestinal tract (GIT) and are subject to first-pass GIT metabolism. Physiological conditions encountered in the GIT such as food effects, hormones, gastric pH, emptying time, and intestinal transit time vary widely across individuals. Fluid composition and enzymatic activity in the small intestine and large bowel also influence drug dissolution and absorption. These factors in conjunction with the intestinal cohort of bacteria can metabolize drugs before absorption, contributing to poor and variable drug bioavailability, which can be exacerbated by gut dysbiosis. Drug delivery that bypasses the oral-GIT route and hence first-pass metabolism offers a plausible solution for enhanced safety and drug efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Sydney School of Pharmacy, Faculty of Medicine and Health, Camperdown Campus, The University of Sydney, Sydney, NSW 2060, Australia.
- Company|Virile Group Level 24, 1 O'Connell Street, Sydney, NSW 2000, Australia.
- Company|Medlab Group, 54 Royal Albert Cres, Paradise Point, QLD 4216, Australia.
- Prince of Wales Clinical School, University of NSW, Sydney, NSW 2052, Australia.
ORCID-Profile: Luis Vitetta, David Rutolo
Zitieren
APA
Vitetta, L., Henson, J. D., Hayes, E., Rutolo, D., & Hall, S. (2025). Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines. Pharmaceuticals, 18(9), 1385. https://doi.org/10.3390/ph18091385
Vancouver
Vitetta L, Henson JD, Hayes E, Rutolo D, Hall S. Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines. Pharmaceuticals. 2025;18(9):1385. doi:10.3390/ph18091385
BibTeX
@article{Vitetta2025,
author = {Vitetta, Luis and Henson, Jeremy David and Hayes, Evan and Rutolo, David and Hall, Sean},
title = {Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {9},
pages = {1385},
doi = {10.3390/ph18091385}
}
EUVIMED